Briacell Therapeutics Corp (BCTX) — Cash Flow Quality Index

Latest as of April 2024: -2.94x

Briacell Therapeutics Corp (BCTX) has a Cash Flow Quality Index of -2.94x as of April 2024. Operating cash flow of $-6.78 Million is below net income of $2.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Briacell Therapeutics Corp (BCTX) cash conversion ratio to assess how effectively this company generates cash.

Cash Flow Quality Index

-2.94x

Operating CF / Net Income

Operating Cash Flow

$-6.78 Million

USD

Net Income

$2.31 Million

USD

Data as of

Apr 2024

Most recent filing

Annual Cash Flow Quality Index for Briacell Therapeutics Corp (None–None)

Year-by-year earnings quality comparison for Briacell Therapeutics Corp. For live market cap and the full company financial profile, see Briacell Therapeutics Corp (BCTX) total market value.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.